Elevations in NNMT activity have been documented across various malignancies, including bladder, breast, colorectal, gastric, lung, oral cavity, ovarian, and prostate cancers, as well as in gliomas, lymphomas, and insulinomas [7,13,14]. The gene discussed is NNMT; the disease is central nervous system cancer.